Ken Fisher Denali Therapeutics Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q2 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 1,515,991 shares of DNLI stock, worth $24.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,515,991
Previous 1,364,959
11.06%
Holding current value
$24.8 Million
Previous $18.6 Million
14.25%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding DNLI
# of Institutions
251Shares Held
134MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$193 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$190 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$108 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$103 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.2B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...